Yamamoto, Kana
Kuriu, Toshihiko https://orcid.org/0000-0001-9125-891X
Matsumura, Kensuke
Nagayasu, Kazuki
Tsurusaki, Yoshinori
Miyake, Noriko
Yamamori, Hidenaga
Yasuda, Yuka
Fujimoto, Michiko
Fujiwara, Mikiya
Baba, Masayuki
Kitagawa, Kohei
Takemoto, Tomoya
Gotoda-Nishimura, Nanaka
Takada, Tomohiro
Seiriki, Kaoru
Hayata-Takano, Atsuko
Kasai, Atsushi https://orcid.org/0000-0002-1612-3078
Ago, Yukio https://orcid.org/0000-0001-7562-4000
Kida, Satoshi https://orcid.org/0000-0002-8038-9583
Takuma, Kazuhiro
Ono, Fumihito https://orcid.org/0000-0001-7532-5262
Matsumoto, Naomichi https://orcid.org/0000-0001-9846-6500
Hashimoto, Ryota
Hashimoto, Hitoshi https://orcid.org/0000-0001-6548-4016
Nakazawa, Takanobu https://orcid.org/0000-0003-4863-1277
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP18H02574, JP20K21464, JP18H05416, JP19H05218, JP20K07057, JP20H03556, JP20H03391, JP20K21479, JP19H05217, JP20H03392, JP17H03989, JP20H00492, JP21K19335, JP18H05416)
Japan Agency for Medical Research and Development (JP20gm1310003, JP20dm0107122, JP20dm0207061, JP20am0101084)
Takeda Science Foundation (ND, ND)
Asahi Glass Foundation (ND)
Naito Foundation (ND)
Article History
Received: 21 August 2021
Revised: 5 October 2021
Accepted: 12 October 2021
First Online: 25 October 2021
COMPETING INTERESTS
: K.Y., K.M., and M. Fujiwara are employed by Chugai Pharmaceutical Co., Ltd, Shionogi & Co., Ltd, and Nippon Shinyaku Co., Ltd, respectively. The remaining authors declare no competing interests.